YSM ranks fourth in US for NIH funding
Yale School of Medicine (YSM) ranked fourth in the nation for total National Institutes of Health (NIH) research funding in 2025, according to the latest report released by the Blue Ridge Institute for Medical Research (BRIMR).
In the federal fiscal year 2025, which ended September 30, 2025, YSM researchers garnered a total of $580,818,286 in NIH awards, as reported by BRIMR, a nonprofit organization based in North Carolina that compiles medical school rankings in NIH funding each year. In the new report, YSM ranked first in microbiology—a BRIMR category that includes YSM researchers in the departments of immunobiology and microbial pathogenesis—up from fourth last year. The Department of Comparative Medicine also ranked first compared to its peers across the country. The departments of emergency medicine and psychiatry were both second in the nation, while YSM ranked third in radiology, rising from eighth in 2024.
New program will focus on rare metabolic disease
The Yale Transketolase Deficiency Program, a new initiative at the Yale School of Medicine, will focus on transketolase deficiency, a rare autosomal recessive hereditary and metabolic disease involving a defect in the enzyme TKT, which is crucial for cellular energy production and the synthesis of nucleotides. The program was established with the help of a gift from Harriet and Leonard Schleifer, whose son was diagnosed with TKT deficiency six years ago by Yale doctors. The Schleifers’ gift is in appreciation for the medical professionals who diagnosed and treated their son: Andrew Wang, associate professor of internal medicine (rheumatology) and of immunobiology; Anna Szekely, assistant professor of neurology; and David Hafler, William S. and Lois Stiles Edgerly Professor of Neurology, professor of immunobiology, and former chair of the Department of Neurology; and to ensure that YSM has the resources needed to advance its research while increasing awareness of TKT deficiency.
loading
Print
Email